NAFDAC Alerts Nigerians To Counterfeit Injection In Circulation
The National Agency for Food and Drug Administration and Control (NAFDAC) has alerted Nigerians, particularly healthcare providers, to one batch of counterfeit Meronem 1g Injection being purchased in Nigeria.
The information is contained in a public alert No. 036/2023, signed by the Director-General of the agency, Prof. Mojisola Adeyeye, and issued to the News Agency of Nigeria (NAN) in Abuja on Tuesday.
Adeyeye said the Marketing Authorization Holder (MAH) Pfizer, reported the incident, as received through a patient notification platform, concerning a suspicious park of Meronem 1g injection purchase.
She reported Pfizer as saying that the vial content did not dissolve when reconstituted for use and that further visual inspection of the pack was observed. It was also reported that the crimp code did not match the code reported on the production documentation batch of 2A21F11, which is the semi-finished batch used for 4A21I17.
More Posts for Show: JUBILEE MORNING DIALOGUE (YORUBA)